← Back to Search

Multifocal Lens

Multifocal Contact Lenses for Near-sightedness (ViPCD3 Trial)

N/A
Recruiting
Led By Marjean T Kulp, OD, MS
Research Sponsored by Visioneering Technologies, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must have no known ocular disease - anterior or posterior (posterior determined by history/chart)
Participants must be between 9 and 30 years of age
Must not have
Using eye medication contraindicating lens wear such as daily use of artificial tears
History of corneal refractive surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the vision performance between two different contact lenses, NaturalVue Multifocal and MiSight, by testing various aspects such as clarity, reading ability, contrast sensitivity, and depth

Who is the study for?
This trial is for individuals with near-sightedness who want to try new daily disposable multifocal lenses. Specific eligibility criteria are not provided, but typically participants should have a stable prescription and no eye diseases.
What is being tested?
The study compares visual performance using two types of contact lenses: NaturalVue Enhanced Multifocal and MiSight. It measures clarity at different contrasts, reading ability, depth perception, focus changes, hand-eye coordination, and vision stability.
What are the potential side effects?
While specific side effects aren't listed for these lenses, common ones may include eye discomfort or dryness, redness or watering eyes. Serious side effects are rare but can involve infections or corneal damage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any known eye diseases.
Select...
I am between 9 and 30 years old.
Select...
I have 20/20 vision in both eyes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I use eye drops daily that prevent me from wearing contact lenses.
Select...
I have had surgery to correct my vision.
Select...
I don't have any eye or systemic conditions that would prevent me from safely wearing contact lenses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Comparison of visual performance (high and low contrast acuity) between VTI NaturalVue Enhanced Multifocal and CooperVision MiSight.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: MiSightActive Control1 Intervention
MiSight 1 Day contact lens
Group II: NaturalVueActive Control1 Intervention
NaturalVue Enhanced Multifocal 1 Day contact lens

Find a Location

Who is running the clinical trial?

Visioneering Technologies, IncLead Sponsor
3 Previous Clinical Trials
248 Total Patients Enrolled
Ohio State UniversityOTHER
866 Previous Clinical Trials
655,094 Total Patients Enrolled
Marjean T Kulp, OD, MSPrincipal InvestigatorThe Ohio State University College of Optometry
~20 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top